this post was submitted on 16 Sep 2023
1166 points (96.1% liked)

Technology

59598 readers
4235 users here now

This is a most excellent place for technology news and articles.


Our Rules


  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots


founded 1 year ago
MODERATORS
 

Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) have developed

you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 7 points 1 year ago (2 children)

What are the 3 candidates you mentioned?

[–] [email protected] 9 points 1 year ago (1 children)

I'll come back in a few hours when I'm on my computer and give you the list. I'm sure others will be interested in it as well.

[–] [email protected] 2 points 1 year ago (1 children)

I asked for a bit more info as well before I saw this response. Thanks.

[–] [email protected] 3 points 1 year ago (1 children)

I posted more information above in this comment: https://lemm.ee/comment/3624282

TAK-101 is a celiac variant of a (currently paused) MS vaccine. I linked a video on that in my other post that may interest you. The video predates the decision to focus on just one disease. Basically the first iteration of their technology wasn't effective, but based on the theory that if it works on one autoimmune disease it should work on all of them, they've switched their focus to celiac because it's easier to test the efficacy. Just measure the amount of IL-2 during a gluten exposure. Also it's cheaper to run one trial than the 5 they had before for various diseases.

The good news is progress is being made on this. But don't expect it any time soon until you can actually book an appointment to get the procedure.

[–] [email protected] 1 points 1 year ago* (last edited 1 year ago)

Thank you. I appreciate you taking the time to respond with more info.

I wasn't expecting much so no worries and not expecting anything soon. I've seen these things for a couple decades now. But this one is interesting. So again thank you.

[–] [email protected] 1 points 1 year ago

I responded to my own comment above with more info, check it out here: https://lemm.ee/comment/3624282